Gryphon Financial Partners’s GSK GSK Stock Holding History

Gryphon Financial Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$817K	Buy	15,580 +2,474	+19%	+$131K	0.07%	174
2026 Q1	$723K	Buy	13,106 +1,464	+13%	+$79.3K	0.07%	176
2025 Q4	$571K	Buy	11,642 +2,145	+23%	+$100K	0.06%	196
2025 Q3	$410K	Buy	9,497 +1,651	+21%	+$64.5K	0.05%	219
2025 Q2	$301K	Buy	7,846 +1,752	+29%	+$66.9K	0.04%	246
2025 Q1	$236K	Buy	+6,094	New	+$223K	0.03%	258
2019 Q1	–	Sell	-4,874	Closed	-$244K	–	134
2018 Q4	$244K	Buy	+4,874	New	+$240K	0.06%	173
2018 Q3	–	Sell	-164	Closed	-$8K	–	436
2018 Q2	$8K	Buy	164 +40	+32%	+$2.02K	﹤0.01%	562
2018 Q1	$6K	Sell	124 -50	-29%	-$2.33K	﹤0.01%	637
2017 Q4	$8K	Buy	+174	New	+$8.04K	﹤0.01%	610

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Gryphon Financial Partners's GSK Position: Q2 2026 in Review

Gryphon Financial Partners increased its GSK (GSK) stake by 19% in Q2 2026, buying an estimated $131K and bringing the position to 15,580 shares worth $817K. The position accounts for 0.07% of the portfolio, ranked #174.

Gryphon Financial Partners first reported a position in GSK in Q4 2017 and has held it in 10 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Gryphon Financial Partners held 15,580 shares of GSK worth $817K as of Q2 2026.
Gryphon Financial Partners bought 2,474 GSK shares in Q2 2026, an estimated $131K.
GSK made up 0.07% of Gryphon Financial Partners's portfolio in Q2 2026, its #174 holding.
Gryphon Financial Partners first reported a position in GSK in Q4 2017 and has held it in 10 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.